IQVIA: Healthcare data regional compliance complexity requires AI, ML and NLP automation
Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more and more frequently. Naturally with more and more people using it for work, new regulations on data use and management are starting to appear.
More Stories
Ethris reports positive phase 1 results for ETH47 mRNA asthma treatment
Munich-based biotechnology company Ethris has announced encouraging topline data from a phase 1 clinical trial evaluating its lead messenger RNA...
Lantheus acquires radiopharma CDMO Evergreen
The US radiopharmaceuticals giant Lantheus is snapping up the Contract Development and Manufacturing (CDMO) Evergreen Theragnostics as it expands its...
Novo Nordisk reports 22% weight loss with amycretin
Novo Nordisk has reported weight loss effects of up to 22% in patients who received a weekly subcutaneous dose of...
Manas AI launches with $24.6 million seed round
The round was led by the US venture capital (VC) firm General Catalyst Partners with participation from compatriot VC Greylock...
Applying data to real-world challenges
Head of solution value at One2Treat, Émilie Barré shares her journey to date with Outsourcing-Pharma.Could you give us an overview...
The largest pharma acquisitions of 2024
Compared to the previous years, 2024 has been a relatively slow year for mergers and acquisitions in the pharmaceutical space....